Arvinas ARVN
NASDAQ ARVN
$9.40 +0.09 (+1.02%)
As of: Sep 4, 2026 · 1:32 PM EDT

Arvinas (ARVN) Other financing activities (2018 - 2022)

Arvinas (ARVN) posted quarterly Other financing activities of $500000.0 for Q4 2022, down 86.84% year-over-year from $3.8 million in Q4 2021, and down 58.33% quarter-over-quarter from $1.2 million in Q3 2022.

Analysis

Arvinas (ARVN) Other financing activities (2018 - 2022) Analysis & Trends

Arvinas' Other financing activities history runs 4 years deep, the most recent figure standing at $500000.0 for Q4 2022.

  • In Q4 2022, Other financing activities fell 86.84% year-over-year to $500000.0; the TTM figure through Dec 2022 stood at $4.7 million (down 74.73% YoY), while the FY2022 annual figure was $4.7 million, down 74.73% from the prior year.
  • Other financing activities for Q4 2022 stood at $500000.0, down from $1.2 million in the prior quarter.
  • The five-year high for Other financing activities was $6.7 million in Q3 2021, with the low at $399488.0 in Q2 2019.
  • The 4-year median for Other financing activities is $1.4 million (2020), against an average of $2.3 million.
  • The sharpest annual moves came in 2021 and 2022: Other financing activities surged 1060.57% in 2021, then tumbled 86.84% in 2022.
  • Arvinas' Other financing activities stood at $1.0 million in 2019, then surged by 398.08% to $5.1 million in 2020, then decreased by 25.39% to $3.8 million in 2021, then sank by 86.84% to $500000.0 in 2022.
  • Business Quant data shows ARVN's Other financing activities at $500000.0 in Q4 2022, $1.2 million in Q3 2022, and $500000.0 in Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Arvinas 609.44 Mn 41.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 500,000.00
Sep 30, 2022 1.20 Mn
Jun 30, 2022 500,000.00
Mar 31, 2022 2.50 Mn
Dec 31, 2021 3.80 Mn
Sep 30, 2021 6.70 Mn
Jun 30, 2021 3.60 Mn
Mar 31, 2021 4.50 Mn
Dec 31, 2020 5.09 Mn
Sep 30, 2020 577,303.00
Jun 30, 2020 1.28 Mn
Mar 31, 2020 1.35 Mn
Dec 31, 2019 -26.65 Mn
Sep 30, 2019 29.05 Mn
Jun 30, 2019 399,488.00
Dec 31, 2018 75,000.00